- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-17-0249259

Biomash Pharmaceuticals Private Limited
About Biomash Pharmaceuticals Private Limited
Data last updated:
Biomash Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 22 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24230RJ2021PTC073623. Its GSTIN is 10AAJCB6557B1Z3 (Bihar).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Manish Kumar and Alka Jaiswal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ews/Ka/62/16 Krishna Apartment Sector – 28 Pratap Nagar, Jaipur, Rajasthan, India – 302033.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.98 Lakh, a decline of 25% compared to the previous year. For the same year it recorded a net profit of ₹5,100 (net margin 0.3%) and EBITDA of ₹17,022 (EBITDA margin 1.1%).
Biomash Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0249259).
Company details
Recognitions & Rankings of Biomash Pharmaceuticals
Contact details
Biomash Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address is in the company report.
- Email
- Registered AddressEws/Ka/62/16 Krishna Apartment Sector – 28 Pratap Nagar, Jaipur, Rajasthan, India – 302033
- IndustryChemicals, Other Chemical Product, Manufacturing
To see the full contact details of Biomash Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Biomash Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Biomash Pharmaceuticals Private Limited, buy the company report.
Financials of Biomash Pharmaceuticals Private Limited
FY 2025 filings availableBiomash Pharmaceuticals Private Limited reported revenue of ₹14.98 Lakh (down 25% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 25% in the latest year. EBITDA fell 36% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹17,022 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹5,100 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.1% | |||
| Net Profit Margin | 0.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Biomash Pharmaceuticals Private Limited, buy the company report.
Board of directors of Biomash Pharmaceuticals Private Limited
Biomash Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Kumar | Director | 22 Feb 2021 | 5 Years 8 Months | Current |
| Alka Jaiswal | Director | 22 Feb 2021 | 5 Years 8 Months | Current |
Peer comparison
Biomash Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stattlich Pharmaceuticals Private Limited | ₹15.03 Lakh (FY 2021) | -8.0% | Amravati, Maharashtra, India | |||
| Biomash Pharmaceuticals Private Limitedthis company | ₹14.98 Lakh (FY 2024) | ₹5,100 | 0.3% | -25.0% | Jaipur, Rajasthan, India | |
| Es Laetus Pharmaceuticals Private Limited | ₹14.95 Lakh (FY 2025) | -4.0% | Kannur, Kerala, India | |||
| Raptakind Pharmaceuticals Private Limited | ₹14.9 Lakh (FY 2024) | 17.0% | Muzaffarpur, Bihar, India | |||
| Dermace Pharmaceuticals Private Limited | ₹14.86 Lakh (FY 2025) | -32.0% | Sikandarpur, Uttar Pradesh, India |
To see the full peer comparison of Biomash Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biomash Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biomash Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biomash Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAJCB6557B1Z3 | Bihar | Active | 04 Mar 2021 |
To see the full GST registrations and return filing status of Biomash Pharmaceuticals Private Limited, buy the company report.
Recent activity
Biomash Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Alka Jaiswal was appointed as Director on 22 Feb 2021.
Frequently asked questions
Biomash Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 22 February 2021 (5+ years old) and is registered under CIN U24230RJ2021PTC073623.
Biomash Pharmaceuticals has 2 current directors:
- Manish Kumar - Director
- Alka Jaiswal - Director
The latest financial statements of Biomash Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Biomash Pharmaceuticals is 10AAJCB6557B1Z3, registered in Bihar.
The CIN (Corporate Identification Number) of Biomash Pharmaceuticals is U24230RJ2021PTC073623. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biomash Pharmaceuticals was incorporated on 22 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Biomash Pharmaceuticals by revenue are Stattlich Pharmaceuticals Private Limited, Es Laetus Pharmaceuticals Private Limited, Raptakind Pharmaceuticals Private Limited, Dermace Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Alka Jaiswal was appointed as Director on 22 Feb 2021. Manish Kumar was appointed as Director on 22 Feb 2021.
Yes, Biomash Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0249259).
The registered office of Biomash Pharmaceuticals is at EwsKa6216 Krishna Apartment Sector – 28 Pratap Nagar, Jaipur, Rajasthan, India – 302033.
Biomash Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.

